<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01799720</url>
  </required_header>
  <id_info>
    <org_study_id>Elena García-García</org_study_id>
    <secondary_id>Enrique Roche Collado</secondary_id>
    <secondary_id>Vicente Micol Molina</secondary_id>
    <secondary_id>Enrique Roche Collado</secondary_id>
    <nct_id>NCT01799720</nct_id>
  </id_info>
  <brief_title>Oxidized Omega-3 Supplements With Different Oxidation</brief_title>
  <acronym>GPTPASPAD</acronym>
  <official_title>Effect of Omega-3 Dietary Supplements With Different Oxidation Levels in the Lipidic Profile of Women: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Miguel Hernandez de Elche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alicante</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Miguel Hernandez de Elche</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The oxidation level of unsaturated fatty acid supplements commercialized in capsules could be
      a serious problem for manufacturers and a risk to consumers; health by ingesting substances
      whose effects are not desired. Therefore, the main objective of this paper is to analyze the
      effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile
      of women who consume these supplements. For this purpose the investigators have designed a
      single-blind, parallel-groups, randomized controlled trial. Finally, 52 women between 25 and
      75 years old were randomly distributed into three groups: (1) took 2 capsules/day of one of
      the less oxidized oil (containing 300 mg EPA + DHA) and diet, (2) took 2 capsules/day of one
      of the most oxidized oil (containing 300 mg EPA + DHA) and diet and (3) no capsules, only
      received the diet. There was a 30 days follow-up . All groups followed a low cholesterol
      diet. Circulating glucose, total cholesterol, triglycerides and glutamic pyruvic transaminase
      were determined at the beginning and end of a 30 day period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The assignment of women to distinct groups was carried out following the classification
      criteria established by (NCEP, 2002), and performed by the research team. Women were randomly
      assigned to one of three parallel groups, in a near 1:1:1 ratio. Group 1 (n=20) took two
      capsules per day of less oxidized oil (containing 300 mg EPA-DHA per capsule) and diet. Group
      2 (n=18) consumed two capsules per day of oxidized oil (containing 300 mg EPA-DHA per
      capsule) and diet. Finally, group 3 (n=19) performed the diet but did not take any capsule.
      Therefore, the design was a single-blind (participants did not know what type of capsule they
      were receiving), parallel-group, randomized controlled trial conducted at the Miguel
      Hernández University of Elche (Spain).

      Statistical analysis was carried out using STATGRAPHICS Centurion XV software (StatPoint
      Technologies, Inc. Warrington, VA); likewise, significance was defined at p&lt;0.05. Data are
      reported as mean standard error of the mean (SEM). Intragroup statistical comparisons were
      performed using the following hypothesis tests, both parametric and non-parametric: t-test,
      sign test and signed rank test for paired samples. Intergroup statistical comparisons were
      performed using the one-way analysis of variance (ANOVA) and the Kruskal-Wallis hypothesis
      tests. Also, Fisher least significant difference (LSD)Multiple Range Test and Tukey HSD were
      used in order to determine which means were significantly different from the others.

      Methods for additional analyses Generalized multiple regression was used to statistically
      analyse the relationships between the variations in the lipid profile and the consumption of
      w-3 dietary supplements.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30)</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the weight (kilogram) of the three intervented groups. Data are mean ± sem.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the height of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the Body Mass Index of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30)</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the hip/waist ratio of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the systolic pressure of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the diastolic pressure of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the glucose of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the cholesterol of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the Triglycerides (TGs) of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</measure>
    <time_frame>Days 1 and 30</time_frame>
    <description>In this table the investigators present the Glutamic Pyruvic Transaminase (GPT) of the three intervented groups. Data are mean ± sem.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Less oxidized oil and diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>More oxidized oil and diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Participants from group 2 took 2 capsules/day of one of the most oxidized oil (containing 300 mg EPA + DHA) and diet . Follow-up 30 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypercholesterolemic diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Participants from group 3 only took diet and no capsules. Follow-up 30 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Less oxidized oil and diet</intervention_name>
    <description>Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Finally 52 women between 25 and 75 years old randomly were distributed into three groups. Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet, . Follow-up 30 days</description>
    <arm_group_label>Less oxidized oil and diet</arm_group_label>
    <other_name>less oxidized oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>More oxidized oil and diet</intervention_name>
    <description>Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Finally 52 women between 25 and 75 years old randomly were distributed into three groups. Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet . Follow-up 30 days</description>
    <arm_group_label>More oxidized oil and diet</arm_group_label>
    <other_name>More oxidized oil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hypercholesterolemic diet</intervention_name>
    <description>Analyze the effect of dietary supplements Omega-3 with different levels of oxidation in the lipid profile of women who consume these supplements. For this purpose we have designed a single-blind, parallel-groups, randomized controlled trial. Finally 52 women between 25 and 75 years old randomly were distributed into three groups. Participants from group 3 only received the diet and no capsules. Follow-up 30 days</description>
    <arm_group_label>Hypercholesterolemic diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of dyslipemia with no indication of drug treatment

          -  blood cholesterol levels ranging 250-300 mg/dL

          -  triglycerides (TG) 160-175 mg/dL

        Exclusion Criteria:

          -  pregnancy

          -  lactation

          -  participation in another supplementary feeding programme
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elena García, PDI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Miguel Hernández University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pharmacy Iborra Campos</name>
      <address>
        <city>Elche</city>
        <state>Alicante</state>
        <zip>03202</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2013</study_first_submitted>
  <study_first_submitted_qc>February 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2013</study_first_posted>
  <results_first_submitted>January 7, 2014</results_first_submitted>
  <results_first_submitted_qc>September 8, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 15, 2014</results_first_posted>
  <last_update_submitted>July 12, 2015</last_update_submitted>
  <last_update_submitted_qc>July 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Miguel Hernandez de Elche</investigator_affiliation>
    <investigator_full_name>Elena García García</investigator_full_name>
    <investigator_title>PhD,PID</investigator_title>
  </responsible_party>
  <keyword>blood cholesterol</keyword>
  <keyword>blood lipid profile</keyword>
  <keyword>triglycerides</keyword>
  <keyword>commercial pills</keyword>
  <keyword>fish oil</keyword>
  <keyword>lipid peroxidation</keyword>
  <keyword>Circulating lipidic profile</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The place where women were recruited for our study was a pharmacy located in the city centre of Elche, during October 2010. Elche is an industrial city located in the Southeast of Spain, with a population of 230 000 inhabitants.</recruitment_details>
      <pre_assignment_details>Before the survey began, 14 people were discarded from the survey because their cholesterol levels were lower than the inclusion standards.
5 participants decided to withdraw from the survey once it had began. 3 of them abandoned the study voluntarily. 1 left because she was pregnant, and 1 violated the protocol norms and was expelled.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Less Oxidized Oil and Diet</title>
          <description>Participants from group 1 took 2 capsules a day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet, Follow-up 30 days</description>
        </group>
        <group group_id="P2">
          <title>More Oxidized Oil and Diet</title>
          <description>Participants from group 2 took 2 capsules a day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet, Follow-up 30 days</description>
        </group>
        <group group_id="P3">
          <title>Diet</title>
          <description>Participants from group 3 took only diet, Follow-up 30 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Began the Treatment</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="19"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Began the Treatment and Finished it</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Less Oxidized Oil and Diet</title>
          <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
        </group>
        <group group_id="B2">
          <title>More Oxidized Oil and Diet</title>
          <description>Participants from group 2 took 2 capsules/day of one of the most oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
        </group>
        <group group_id="B3">
          <title>Only Diet</title>
          <description>Participants from group 3 only received the diet. Follow-up 30 days.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="18"/>
            <count group_id="B4" value="52"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.65" spread="12.65"/>
                    <measurement group_id="B2" value="56.82" spread="12.18"/>
                    <measurement group_id="B3" value="51.94" spread="10.80"/>
                    <measurement group_id="B4" value="55.14" spread="11.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="18"/>
                    <measurement group_id="B4" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30)</title>
        <description>In this table the investigators present the weight (kilogram) of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Weight (Kilogram) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30)</title>
          <description>In this table the investigators present the weight (kilogram) of the three intervented groups. Data are mean ± sem.</description>
          <units>kilogram</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.17" spread="3.71"/>
                    <measurement group_id="O2" value="68.77" spread="3.42"/>
                    <measurement group_id="O3" value="75.15" spread="3.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.38" spread="3.61"/>
                    <measurement group_id="O2" value="67.78" spread="3.41"/>
                    <measurement group_id="O3" value="74.29" spread="3.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
        <description>In this table the investigators present the height of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Height (Metre) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
          <description>In this table the investigators present the height of the three intervented groups. Data are mean ± sem.</description>
          <units>metres</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.60" spread="0.02"/>
                    <measurement group_id="O2" value="1.59" spread="0.01"/>
                    <measurement group_id="O3" value="1.61" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.60" spread="0.02"/>
                    <measurement group_id="O2" value="1.59" spread="0.01"/>
                    <measurement group_id="O3" value="1.61" spread="0.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
        <description>In this table the investigators present the Body Mass Index of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Body Mass Index (BMI) (Kg/m2) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
          <description>In this table the investigators present the Body Mass Index of the three intervented groups. Data are mean ± sem.</description>
          <units>kilogram / square metre</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.43" spread="1.41"/>
                    <measurement group_id="O2" value="28.65" spread="2.13"/>
                    <measurement group_id="O3" value="29.00" spread="1.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.10" spread="1.34"/>
                    <measurement group_id="O2" value="26.94" spread="1.36"/>
                    <measurement group_id="O3" value="28.64" spread="1.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30)</title>
        <description>In this table the investigators present the hip/waist ratio of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Hip/Waist Ratio of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30)</title>
          <description>In this table the investigators present the hip/waist ratio of the three intervented groups. Data are mean ± sem.</description>
          <units>ratio*100</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.5" spread="2.1"/>
                    <measurement group_id="O2" value="87.2" spread="3.0"/>
                    <measurement group_id="O3" value="86.0" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.5" spread="2.1"/>
                    <measurement group_id="O2" value="87.2" spread="3.0"/>
                    <measurement group_id="O3" value="86.0" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
        <description>In this table the investigators present the systolic pressure of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
          <description>In this table the investigators present the systolic pressure of the three intervented groups. Data are mean ± sem.</description>
          <units>millimetres of mercury</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="129.9" spread="0.50"/>
                    <measurement group_id="O2" value="123.7" spread="0.66"/>
                    <measurement group_id="O3" value="118.6" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="118.2" spread="0.42"/>
                    <measurement group_id="O2" value="120.2" spread="0.41"/>
                    <measurement group_id="O3" value="119.4" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
        <description>In this table the investigators present the diastolic pressure of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Diastolic Pressure (mmHg) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
          <description>In this table the investigators present the diastolic pressure of the three intervented groups. Data are mean ± sem.</description>
          <units>millimetres of mercury</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.2" spread="0.26"/>
                    <measurement group_id="O2" value="73.9" spread="0.34"/>
                    <measurement group_id="O3" value="73.3" spread="0.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.9" spread="0.21"/>
                    <measurement group_id="O2" value="75.1" spread="0.29"/>
                    <measurement group_id="O3" value="72.8" spread="0.20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
        <description>In this table the investigators present the glucose of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Glucose (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
          <description>In this table the investigators present the glucose of the three intervented groups. Data are mean ± sem.</description>
          <units>milligram / decilitre</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="103.35" spread="3.18"/>
                    <measurement group_id="O2" value="108.96" spread="11.11"/>
                    <measurement group_id="O3" value="99.72" spread="4.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116.24" spread="4.30"/>
                    <measurement group_id="O2" value="111.37" spread="2.46"/>
                    <measurement group_id="O3" value="108.26" spread="2.55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
        <description>In this table the investigators present the cholesterol of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Cholesterol (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
          <description>In this table the investigators present the cholesterol of the three intervented groups. Data are mean ± sem.</description>
          <units>milligram / decilitre</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="246.64" spread="12.92"/>
                    <measurement group_id="O2" value="232.94" spread="12.55"/>
                    <measurement group_id="O3" value="236.78" spread="4.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="217.76" spread="8.98"/>
                    <measurement group_id="O2" value="237.52" spread="7.54"/>
                    <measurement group_id="O3" value="227.22" spread="6.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
        <description>In this table the investigators present the Triglycerides (TGs) of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Triglycerides (TGs) (mg/dL) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
          <description>In this table the investigators present the Triglycerides (TGs) of the three intervented groups. Data are mean ± sem.</description>
          <units>milligram / decilitre</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164.41" spread="15.43"/>
                    <measurement group_id="O2" value="160.41" spread="11.34"/>
                    <measurement group_id="O3" value="174.83" spread="19.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="125.52" spread="12.34"/>
                    <measurement group_id="O2" value="116.88" spread="11.43"/>
                    <measurement group_id="O3" value="130.04" spread="10.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
        <description>In this table the investigators present the Glutamic Pyruvic Transaminase (GPT) of the three intervented groups. Data are mean ± sem.</description>
        <time_frame>Days 1 and 30</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Less Oxidized Oil and Diet</title>
            <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O2">
            <title>More Oxidized Oil and Diet</title>
            <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
          </group>
          <group group_id="O3">
            <title>Diet</title>
            <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
          </group>
        </group_list>
        <measure>
          <title>Glutamic Pyruvic Transaminase (GPT) (U/L) of Volunteers at the Beginning (Day 1) and at the End of the Study (Day 30).</title>
          <description>In this table the investigators present the Glutamic Pyruvic Transaminase (GPT) of the three intervented groups. Data are mean ± sem.</description>
          <units>Units / litre</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.70" spread="2.71"/>
                    <measurement group_id="O2" value="24.90" spread="2.96"/>
                    <measurement group_id="O3" value="23.54" spread="3.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 30</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.69" spread="3.34"/>
                    <measurement group_id="O2" value="18.46" spread="1.62"/>
                    <measurement group_id="O3" value="19.94" spread="2.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>5 participants decided to withdraw from the survey once it had began. 3 of them abandoned the study voluntarily. 1 left because she was pregnant, and 1 violated the protocol norms and was expelled.</desc>
      <group_list>
        <group group_id="E1">
          <title>Less Oxidized Oil and Diet</title>
          <description>Participants from group 1 took 2 capsules/day of one of the less oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
        </group>
        <group group_id="E2">
          <title>More Oxidized Oil and Diet</title>
          <description>Participants from group 2 took 2 capsules/day of one of the more oxidized oil (containing 300 mg EPA + DHA) and diet. Follow-up 30 days.</description>
        </group>
        <group group_id="E3">
          <title>Diet</title>
          <description>Participants from group 3 only took diet. Follow-up 30 days.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>protocol violation</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Violation of protocol norms</sub_title>
                <description>The participant did not follow the rules and the diet</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title vocab="abandonment">Study abandonment</sub_title>
                <description>The participants lost interest in the diet and deciced to abandon the study</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="20"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="19"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Elena García García</name_or_title>
      <organization>Universidad Miguel Hernández</organization>
      <phone>965222025 ext 2025</phone>
      <email>egarcia@umh.es</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

